智通财经APP获悉，周五，Akoya Biosciences(AKYA.US)股价走高，截至发稿，该股涨超16%，报3.09美元。该公司宣布与Quanterix(QTRX.US)达成全股票合并协议。根据协议，交易预计将于2025年第二季度完成。合并后公司将以Quanterix名义运营，由Quanterix现任首席执行官Masoud Toloue领导。完成交易后，Quanterix股东将拥有合并后公司约70%的股份。此次合并将整合两家公司在生命科学领域的资源与技术，预计为股东和客户带来更大的价值。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.